Gilead Sciences Inc. (GILD) — This biopharmaceutical company engages in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases.

The swine-flu scare will no doubt have a positive impact on GILD since it could be a major manufacturer of any serum production to combat the new strain.

Further, GILD is trading in a huge triangle, which, if penetrated on the upside, could yield an above average return.

A break above the 200-day moving average at $48 could lead to a challenge of the bearish resistance line at $52 and lead to new high with a target of about $75.

Get Sam Collins’ Daily Trader’s Alert e-mailed straight to your inbox each morning before the opening bell absolutely FREE!

In addition to getting instant access to his Trade of the Day, you’ll also receive, in the same e-mail, his Daily Market Outlook so you can start your day off right by positioning yourself for profits!

Click here today to sign up today for Sam’s FREE Daily Trader’s Alert!

Sam Collins is a registered, fee-based portfolio manager who may be contacted samailc@cox.net. You can also check out an archive of some of his most recent market outlooks by clicking here.